Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease

被引：0
|
作者：
Jurij Hanzel
Christopher Ma
Niels Vande Casteele
Reena Khanna
Vipul Jairath
Brian G. Feagan
机构：
[1] University Medical Center Ljubljana,Department of Gastroenterology
[2] Alimentiv,Division of Gastroenterology and Hepatology, Cumming School of Medicine
[3] University of Calgary,Department of Medicine
[4] University of California San Diego,Division of Gastroenterology
[5] University of Western Ontario,Department of Epidemiology and Biostatistics
[6] University of Western Ontario,Department of Medicine
[7] University of Western Ontario,undefined
来源：
Drugs | 2021年 / 81卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1697 / 1697
相关论文
共 50 条
  • [1] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Hanzel, Jurij
    Ma, Christopher
    Vande Casteele, Niels
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    DRUGS, 2021, 81 (03) : 333 - 347
  • [2] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 333 - 347
  • [3] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S19 - S20
  • [4] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [5] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2020, 158 (03) : S32 - S33
  • [6] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth W.
    Proctor, Deborah D.
    Ruggiero, Elizabeth
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2020, 158 (06) : S675 - S675
  • [7] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [8] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fleisher, Mark
    Marsal, Jan
    Lee, Scott D.
    Frado, Laura E.
    Parian, Alyssa
    Korelitz, Burton I.
    Feagan, Brian G.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (04) : 825 - 833
  • [9] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Mark Fleisher
    Jan Marsal
    Scott D. Lee
    Laura E. Frado
    Alyssa Parian
    Burton I. Korelitz
    Brian G. Feagan
    Digestive Diseases and Sciences, 2018, 63 : 825 - 833
  • [10] VEDOLIZUMAB INDUCES DE NOVO EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Kim, Su Bin
    Diaz, Liege I.
    Calmet, Fernando
    Quintero, Maria A.
    Schwartz, Ingrid
    Abreu, Maria T.
    GASTROENTEROLOGY, 2018, 154 (06) : S360 - S360
12345